FR2392016A1 - Derives de mevalonolactone, leur procede de preparation et leur application therapeutique - Google Patents

Derives de mevalonolactone, leur procede de preparation et leur application therapeutique

Info

Publication number
FR2392016A1
FR2392016A1 FR7815488A FR7815488A FR2392016A1 FR 2392016 A1 FR2392016 A1 FR 2392016A1 FR 7815488 A FR7815488 A FR 7815488A FR 7815488 A FR7815488 A FR 7815488A FR 2392016 A1 FR2392016 A1 FR 2392016A1
Authority
FR
France
Prior art keywords
preparation process
therapeutic application
mevalonolactone derivatives
mevalonolactone
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7815488A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of FR2392016A1 publication Critical patent/FR2392016A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La présente invention est relative à des dérivés de mévalonolactone répondant à la formule ci-dessous :
FR7815488A 1977-05-24 1978-05-24 Derives de mevalonolactone, leur procede de preparation et leur application therapeutique Withdrawn FR2392016A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6011077A JPS53147073A (en) 1977-05-24 1977-05-24 Mevalonolactone derivatives

Publications (1)

Publication Number Publication Date
FR2392016A1 true FR2392016A1 (fr) 1978-12-22

Family

ID=13132633

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7815488A Withdrawn FR2392016A1 (fr) 1977-05-24 1978-05-24 Derives de mevalonolactone, leur procede de preparation et leur application therapeutique

Country Status (9)

Country Link
US (2) US4198425A (fr)
JP (1) JPS53147073A (fr)
BE (1) BE867421A (fr)
DE (1) DE2822848A1 (fr)
ES (1) ES470209A1 (fr)
FR (1) FR2392016A1 (fr)
GB (1) GB1586152A (fr)
NL (1) NL7805647A (fr)
SE (1) SE7805879L (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0010951A1 (fr) * 1978-10-30 1980-05-14 Sankyo Company Limited Dérivés de 4-hydroxy-2-pyrones, procédé pour leur préparation et leurs préparations pharmaceutiques
EP0024348A1 (fr) * 1979-08-17 1981-03-04 Merck & Co. Inc. 6-Phényléthyl et phényléthényl-3,4,5,6-tétrahydro-4-hydroxytétrahydropyran-2-ones substitués dans les formes stéréoisomères 4-R-trans et les acides dihydroxylées correspondantes, procédé de leur préparation et composition pharmaceutique les comprenant
EP0189142A2 (fr) * 1985-01-17 1986-07-30 Usv Pharmaceutical Corporation Alcools arylalcoxyphénylallyliques pour le traitement d'une hypersensibilité à la douleur
EP0302253A1 (fr) * 1987-07-10 1989-02-08 Hoechst Aktiengesellschaft Dérivés d'acide 3-déméthyl-4-fluoro-mévalonique, procédé pour leur préparation, préparations pharmaceutiques à base de ces composés, leur utilisation et intermédiaires

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA18559A1 (fr) * 1978-09-05 1980-04-01 Hoechst Lab Nouveaux derives d'acides carboxyliques 6-alcools, halogenes, leurs procedes de preparation et medicaments les contenant
US4459422A (en) * 1979-08-17 1984-07-10 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
US4375475A (en) * 1979-08-17 1983-03-01 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
US4710513A (en) * 1979-08-17 1987-12-01 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
US4567289A (en) * 1979-08-17 1986-01-28 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
US4322563A (en) 1980-04-14 1982-03-30 Merck & Co., Inc. Substituted biphenyl-2-carboxaldehydes
US4308378A (en) * 1980-09-02 1981-12-29 Merck & Co., Inc. Cis/trans isomerization of 6-(substituted-aryl-ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-ones
US4440927A (en) * 1981-06-19 1984-04-03 Merck & Co., Inc. Process for preparing inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase via a chiral synthon
US5354772A (en) * 1982-11-22 1994-10-11 Sandoz Pharm. Corp. Indole analogs of mevalonolactone and derivatives thereof
US4588715A (en) * 1984-06-04 1986-05-13 Sandoz, Inc. Heptenoic acid derivatives
US4588820A (en) * 1984-06-11 1986-05-13 Merck & Co., Inc. Process for epimerization at C6 of 3,4,5,6-tetrahydro-2H-pyran-2-one
US4613610A (en) * 1984-06-22 1986-09-23 Sandoz Pharmaceuticals Corp. Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives
US4686237A (en) * 1984-07-24 1987-08-11 Sandoz Pharmaceuticals Corp. Erythro-(E)-7-[3'-C1-3 alkyl-1'-(3",5"-dimethylphenyl)naphth-2'-yl]-3,5-dihydroxyhept-6-enoic acids and derivatives thereof
US4804679A (en) * 1984-07-24 1989-02-14 Sandoz Pharm. Corp. Erythro-(E)-7-(3'-C1-3alkyl-1'-(3",5"-dimethylphenyl)naphth-2'-yl)-3,5-dihydroxyhept-6-enoic acids and derivatives thereof
US4647576A (en) * 1984-09-24 1987-03-03 Warner-Lambert Company Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
US5001255A (en) * 1984-12-04 1991-03-19 Sandoz Pharm. Corp. Idene analogs of mevalonolactone and derivatives thereof
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs
JPS6282997A (ja) * 1985-10-04 1987-04-16 株式会社森本製作所 多針式ミシンの縫製装置
US4851427A (en) * 1985-10-25 1989-07-25 Sandoz Pharm. Corp. Pyrrole analogs of mevalonolactone, derivatives thereof and pharmaceutical use
US4654363A (en) * 1985-11-04 1987-03-31 Merck & Co., Inc. Synthetic analogs of mevinolin
DE3615620A1 (de) * 1986-05-09 1987-11-12 Hoechst Ag 4(r)-substituierte 6(s)-phenoxymethyl-, 6(s)-(beta)-phenylaethyl-und 6(s)-(beta)-styryl-tetrahydropyran-2-one, ein hochstereoselektives verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
US4681893A (en) * 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US4808733A (en) * 1986-06-09 1989-02-28 Stauffer Chemical Company Certain 4-oxo-3-benzoylvalerolactones and thiolactones
US5102893A (en) * 1986-07-07 1992-04-07 Warner-Lambert Company Trans-6-(2-(n-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl- or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
US4957971A (en) * 1986-07-07 1990-09-18 Warner-Lambert Company Trans-6-(2-(N-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl)-or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
US4898949A (en) * 1987-02-25 1990-02-06 Bristol-Myers Company Intermediates for the preparation of antihypercholesterolemic tetrazole compounds
US4897490A (en) * 1987-02-25 1990-01-30 Bristol-Meyers Company Antihypercholesterolemic tetrazole compounds
US5036105A (en) * 1987-05-07 1991-07-30 G. D. Searle & Co. 5-lipoxygenase inhibitors
US5162365A (en) * 1987-05-07 1992-11-10 G. D. Searle & Co. 5-lipoxygenase inhibitors
US4801611A (en) * 1987-05-07 1989-01-31 G. D. Searle & Co. 5-lipoxygenase inhibitors
US5091378A (en) * 1987-05-22 1992-02-25 E. R. Squibb & Sons, Inc. Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and method
US4904646A (en) * 1987-05-22 1990-02-27 E. R. Squibb & Sons, Inc. Phosphorus-containing HMG-COA reductase inhibitors
US5151545A (en) * 1987-10-13 1992-09-29 Pfizer Inc. 3,5-dihydroxy-6,8-nonadienoic acids and derivatives as hypocholesterolemic agents
WO1989004821A1 (fr) * 1987-11-25 1989-06-01 Pfizer Inc. Acide glutaramique de n-(biphenylmethyl)-3-hydroxy et ses derives a titre d'agents hypocholesterolemiques
US4761419A (en) * 1987-12-07 1988-08-02 Warner-Lambert Company 6-(((substituted)quinolinyl)ethyl)-and ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
US4863957A (en) * 1987-12-21 1989-09-05 Rorer Pharmaceutical Corporation Novel HMG-CoA reductase inhibitors
US5010205A (en) * 1988-08-23 1991-04-23 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl intermediates
US5506219A (en) * 1988-08-29 1996-04-09 E. R. Squibb & Sons, Inc. Pyridine anchors for HMG-CoA reductase inhibitors
US4957940A (en) * 1988-12-21 1990-09-18 Warner-Lambert Company Bicyclo heptane and bicyclo octane substituted inhibitors of cholesterol synthesis
US4906657A (en) * 1988-12-21 1990-03-06 Warner-Lambert Company Bicyclo heptane and bicyclo octane substituted inhibitors of cholesterol synthesis
US5025017A (en) * 1989-09-28 1991-06-18 E. R. Squibb & Sons, Inc. Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates
US5189180A (en) * 1989-09-28 1993-02-23 E. R. Squibb & Sons, Inc. Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates
WO1992019240A1 (fr) * 1991-05-01 1992-11-12 University Of New Mexico Traitement d'aberrations cellulaires avec des biomodulateurs
WO1992019239A1 (fr) * 1991-05-01 1992-11-12 University Of New Mexico Traitement d'etats cellulaires aberrants a l'aide de biomodulateurs
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
IL113567A0 (en) * 1994-05-06 1995-08-31 Upjohn Co Compounds useful to treat retroviral infections
US5665333A (en) * 1995-01-17 1997-09-09 Homola; Andrew M. Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth
US5961958A (en) * 1996-07-16 1999-10-05 Four Star Partners Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth
US20010006644A1 (en) 1997-07-31 2001-07-05 David J. Bova Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night
US20040248972A1 (en) * 2003-05-16 2004-12-09 Ambit Biosciences Corporation Compounds and uses thereof
US20050182125A1 (en) * 2003-05-16 2005-08-18 Ambit Biosciences Corporation Pyrrole compounds and uses thereof
US20040242673A1 (en) * 2003-05-16 2004-12-02 Ambit Biosciences Corporation Heterocyclic compounds and uses thereof
US7250444B2 (en) * 2003-08-11 2007-07-31 Pfizer Inc. Pyrrole-based HMG-CoA reductase inhibitors
CA2547573A1 (fr) * 2003-12-05 2005-06-23 Warner-Lambert Company Llc Pyrroles de n-alkyl comme inhibiteurs de l'hmg-coa-reductase
KR100836960B1 (ko) 2007-09-07 2008-06-10 주식회사 서울제약 새로운 나이아신 제어방출형 제제
US8563066B2 (en) 2007-12-17 2013-10-22 New World Pharmaceuticals, Llc Sustained release of nutrients in vivo
WO2010019680A1 (fr) * 2008-08-12 2010-02-18 Homola Andrew M Formulations pour système de délivrance active
US20170202789A1 (en) 2014-07-16 2017-07-20 New World Pharmaceuticals, Llc Methods and related compositions for improved drug bioavailability and disease treatment
WO2016056658A1 (fr) * 2014-10-10 2016-04-14 株式会社エーピーアイ コーポレーション Procédé de purification de composé statine
EP3277274B1 (fr) 2015-04-01 2024-06-12 Cedars-Sinai Medical Center Analogues ou dérivés de lovastatine anti-méthanogènes et leurs utilisations

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2098755A5 (en) * 1970-07-27 1972-03-10 Laire Produits Chimie Mevalolactone and its homologues - prepd from 4-hydroxy-2-butanone and an acid

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3119842A (en) * 1961-03-22 1964-01-28 Frank H Hulcher Process for the synthesis of mevalonic acid and its lactone and derivatives thereof
US3075997A (en) * 1961-10-24 1963-01-29 Olin Mathieson 3, 5-dihydroxy-3-fluoro-methylpentanoic acid and the delta lactone thereof
US3346594A (en) * 1965-08-25 1967-10-10 Gen Aniline & Film Corp Haloalkyl and polyhaloalkyl lactones
DE1617812A1 (de) 1967-06-05 1972-02-17 Spezialchemie Gmbh & Co Verfahren zur Herstellung von endoanaesthetisch wirkenden Loesungen von Kava-Wirkstoffen
US3522245A (en) * 1967-07-26 1970-07-28 Spezialchemie Gmbh & Co 4 - oxo - 6 - styryl - 3,4;5,6 - tetrahydro - alpha-pyron compounds,compositions containing same,and process of making same
US3600403A (en) * 1967-11-24 1971-08-17 Spezialchemie Gmbh & Co Hydrogenation of pyrone compounds
JPS5612114B2 (fr) * 1974-06-07 1981-03-18
JPS5119760A (fr) * 1974-08-09 1976-02-17 Nippon Soda Co

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2098755A5 (en) * 1970-07-27 1972-03-10 Laire Produits Chimie Mevalolactone and its homologues - prepd from 4-hydroxy-2-butanone and an acid

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0010951A1 (fr) * 1978-10-30 1980-05-14 Sankyo Company Limited Dérivés de 4-hydroxy-2-pyrones, procédé pour leur préparation et leurs préparations pharmaceutiques
EP0024348A1 (fr) * 1979-08-17 1981-03-04 Merck & Co. Inc. 6-Phényléthyl et phényléthényl-3,4,5,6-tétrahydro-4-hydroxytétrahydropyran-2-ones substitués dans les formes stéréoisomères 4-R-trans et les acides dihydroxylées correspondantes, procédé de leur préparation et composition pharmaceutique les comprenant
EP0189142A2 (fr) * 1985-01-17 1986-07-30 Usv Pharmaceutical Corporation Alcools arylalcoxyphénylallyliques pour le traitement d'une hypersensibilité à la douleur
EP0189142A3 (fr) * 1985-01-17 1987-09-16 Usv Pharmaceutical Corporation Alcools arylalcoxyphénylallyliques pour le traitement d'une hypersensibilité à la douleur
EP0302253A1 (fr) * 1987-07-10 1989-02-08 Hoechst Aktiengesellschaft Dérivés d'acide 3-déméthyl-4-fluoro-mévalonique, procédé pour leur préparation, préparations pharmaceutiques à base de ces composés, leur utilisation et intermédiaires
US4898868A (en) * 1987-07-10 1990-02-06 Hoechst Aktiengesellschaft 3-demethyl-4-fluoromevalonic acid derivatives, a process for the preparation thereof, pharmaceutical products based on these compounds, the use thereof, and intermediates

Also Published As

Publication number Publication date
US4262013A (en) 1981-04-14
JPS53147073A (en) 1978-12-21
NL7805647A (nl) 1978-11-28
SE7805879L (sv) 1978-11-25
US4198425A (en) 1980-04-15
BE867421A (fr) 1978-11-24
JPS6135987B2 (fr) 1986-08-15
ES470209A1 (es) 1979-09-16
GB1586152A (en) 1981-03-18
DE2822848A1 (de) 1978-11-30

Similar Documents

Publication Publication Date Title
FR2392016A1 (fr) Derives de mevalonolactone, leur procede de preparation et leur application therapeutique
FR2385722A1 (fr) Nouveaux derives de cephalosporine, leur procede de preparation et leur application en therapeutique
FR2372822A1 (fr) Derives polyoxygenes du labdane, leurs procedes de preparation et leur application
FR2406641A1 (fr) 2,6-diaminonebularines et leur application therapeutique
FR2400010A1 (fr) Procede de preparation de sulfobetaines
FR2364219A1 (fr) Derives de thiazolidine, leur procede de preparation et leur application en therapeutique
FR2405246A1 (fr) Nouveaux derives de pyrrole, leur procede de preparation et leurs applications en therapeutique
FR2446283A1 (fr) Phenoxyphenylpiperidines, leur preparation et leurs applications therapeutiques
FR2387988A1 (fr) Esters de cefuroxime, leur preparation et leur application therapeutique
FR2381753A1 (fr) Nouveaux derives de la pyrrolidine, leur procede de preparation et leur application en therapeutique
FR2384811A1 (fr) Derives de la neocarzinostatine, leur application therapeutique et leur procede de preparation
FR2421900A1 (fr) Piperazino-3-indoles, leur procede de preparation et leurs applications therapeutiques
FR2387214A1 (fr) Derives du p-aminomethyl benzene-sulfonamide, leur procede de preparation et leur application therapeutique
FR2398058A1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
FR2388789A1 (fr) Derives d'acide benzoique, leur procede de preparation et leur application therapeutique
FR2388804A1 (fr) Nouveaux derives des acides oxazole- et thiazole-alkanoiques et leur application en therapeutique humaine
FR2443457A1 (fr) Derives de 1-phenyl-2-amino-1-propanol, leur procede de preparation et leur utilisation comme medicaments
FR2358401A1 (fr) Nouveaux derives d'oxadiazine, leur procede de preparation et leur application comme insecticides
FR2361352A1 (fr) Derives acylamino (alkyl)-benzeniques, leur procede de preparation et leur application
FR2386547A1 (fr) Nouveaux derives de la pyrido-(2,3-b)benzothiazepine-(1,5) substitues en position 5, leur procede de preparation et leur application pharmaceutique
FR2368489A1 (fr) Derives de la clavuline, leur procede de preparation et leur application en therapeutique
FR2385670A1 (fr) Procede de preparation de 2,2-dimethylolalcanals
FR2415107A1 (fr) Derives de 5-phenethyl-2-oxazolidone, leur procede de preparation et leur application en therapeutique
FR2390432A1 (fr) Benzene-sulfonyl urees, leur procede de preparation et leur application therapeutique
FR2400005A1 (fr) Derives de l'alcool benzylique, leur procede de fabrication et leur application comme medicaments

Legal Events

Date Code Title Description
ST Notification of lapse